blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2093228

EP2093228 - PYRROLINE-2-ONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR, PREPARATION METHODS AND USES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.12.2012
Database last updated on 15.06.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Tianjin Hemay Bio-Tech Co., Ltd
Xiao Yuan Xin Cun
31-101 Teda
Tianjin 300457 / CN
[N/P]
Former [2009/35]For all designated states
Tianjin Hemey Bio-Tech Co., Ltd.
Xiao Yuan Xin Cun, 31-101 Teda
Tianjin 300457 / CN
Inventor(s)01 / ZHANG, Hesheng
Xiao Yuan Xin Cun
31-101 Teda
Tianjin 300457 / CN
 [2012/08]
Former [2009/35]01 / ZHANG, Hesheng
Xiao Yuan Xin Cun 31-101 Teda
Tianjin 300457 / CN
Representative(s)Korga, Leokadia, et al
Kancelaria Rzecznika Patentowego
ul. Bereniki 6/7
44-117 Gliwice / PL
[N/P]
Former [2009/35]Korga, Leokadia, et al
Kancelaria Rzecznika Patentowego ul. Bereniki 6/7
44-117 Gliwice / PL
Application number, filing date07816580.016.10.2007
[2009/35]
WO2007CN02966
Priority number, dateCN20061012942015.11.2006         Original published format: CN200610129420
[2009/35]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008058449
Date:22.05.2008
Language:ZH
[2008/21]
Type: A1 Application with search report 
No.:EP2093228
Date:26.08.2009
Language:EN
[2009/35]
Type: B1 Patent specification 
No.:EP2093228
Date:22.02.2012
Language:EN
[2012/08]
Search report(s)International search report - published on:CN22.05.2008
(Supplementary) European search report - dispatched on:EP09.10.2009
ClassificationIPC:C07D495/04, C07D487/04, A61K31/4365, A61K31/437, A61P35/00, A61P31/00, A61P37/00, A61P9/00, A61P9/10, A61P5/00
[2009/35]
CPC:
C07D487/04 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P13/12 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P19/02 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P3/14 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P43/00 (EP);
A61P5/00 (EP); A61P7/00 (EP); A61P9/00 (EP);
A61P9/10 (EP); C07D495/04 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/35]
Extension statesAL15.06.2009
BA15.06.2009
HR15.06.2009
MK15.06.2009
RS15.06.2009
TitleGerman:PYRROLIN-2-ON-DERIVATE GEGEN TUMORNEKROSEFAKTOR FREISETZENDE ZELLEN, HERSTELLUNGSVERFAHREN UND ANWENDUNGEN DAVON[2009/35]
English:PYRROLINE-2-ONE DERIVATIVES AGAINST CELL RELEASING TUMOR NECROSIS FACTOR, PREPARATION METHODS AND USES THEREOF[2009/35]
French:DÉRIVÉS DE PYRROLINE-2-ONE UTILISÉS CONTRE LE FACTEUR DE NÉCROSE TUMORALE À LIBÉRATION CELLULAIRE, PROCÉDÉS DE PRÉPARATION ET UTILISATIONS DE CEUX-CI[2009/35]
Entry into regional phase15.06.2009Translation filed 
31.03.2009National basic fee paid 
31.03.2009Search fee paid 
31.03.2009Designation fee(s) paid 
31.03.2009Examination fee paid 
Examination procedure31.03.2009Examination requested  [2009/35]
22.01.2010Despatch of a communication from the examining division (Time limit: M04)
26.05.2010Reply to a communication from the examining division
27.09.2011Communication of intention to grant the patent
13.01.2012Fee for grant paid
13.01.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  22.01.2010
Opposition(s)23.11.2012No opposition filed within time limit [2013/05]
Fees paidRenewal fee
20.10.2009Renewal fee patent year 03
09.10.2010Renewal fee patent year 04
28.09.2011Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.10.2007
AT22.02.2012
BE22.02.2012
CY22.02.2012
CZ22.02.2012
DK22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
MT22.02.2012
NL22.02.2012
PL22.02.2012
RO22.02.2012
SE22.02.2012
SI22.02.2012
SK22.02.2012
TR22.02.2012
BG22.05.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
IE16.10.2012
LU16.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
[2014/34]
Former [2014/27]AT22.02.2012
BE22.02.2012
CY22.02.2012
CZ22.02.2012
DK22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
MT22.02.2012
NL22.02.2012
PL22.02.2012
RO22.02.2012
SE22.02.2012
SI22.02.2012
SK22.02.2012
TR22.02.2012
BG22.05.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
IE16.10.2012
LU16.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
Former [2014/21]AT22.02.2012
BE22.02.2012
CY22.02.2012
CZ22.02.2012
DK22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
MT22.02.2012
NL22.02.2012
PL22.02.2012
RO22.02.2012
SE22.02.2012
SI22.02.2012
SK22.02.2012
TR22.02.2012
BG22.05.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
IE16.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
Former [2013/51]AT22.02.2012
BE22.02.2012
CY22.02.2012
CZ22.02.2012
DK22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
MT22.02.2012
NL22.02.2012
PL22.02.2012
RO22.02.2012
SE22.02.2012
SI22.02.2012
SK22.02.2012
BG22.05.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
IE16.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
Former [2013/33]AT22.02.2012
BE22.02.2012
CY22.02.2012
CZ22.02.2012
DK22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
NL22.02.2012
PL22.02.2012
RO22.02.2012
SE22.02.2012
SI22.02.2012
SK22.02.2012
BG22.05.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
IE16.10.2012
CH31.10.2012
LI31.10.2012
MC31.10.2012
Former [2013/24]AT22.02.2012
BE22.02.2012
CY22.02.2012
CZ22.02.2012
DK22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
NL22.02.2012
PL22.02.2012
RO22.02.2012
SE22.02.2012
SI22.02.2012
SK22.02.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
MC31.10.2012
Former [2013/07]AT22.02.2012
BE22.02.2012
CY22.02.2012
CZ22.02.2012
DK22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
NL22.02.2012
PL22.02.2012
RO22.02.2012
SE22.02.2012
SI22.02.2012
SK22.02.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
Former [2012/50]BE22.02.2012
CY22.02.2012
CZ22.02.2012
DK22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
NL22.02.2012
PL22.02.2012
RO22.02.2012
SE22.02.2012
SI22.02.2012
SK22.02.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
Former [2012/49]BE22.02.2012
CY22.02.2012
CZ22.02.2012
DK22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
NL22.02.2012
PL22.02.2012
RO22.02.2012
SE22.02.2012
SI22.02.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
Former [2012/48]BE22.02.2012
CY22.02.2012
EE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
NL22.02.2012
SE22.02.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
Former [2012/41]BE22.02.2012
CY22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
NL22.02.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
Former [2012/39]BE22.02.2012
FI22.02.2012
LT22.02.2012
LV22.02.2012
NL22.02.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
Former [2012/37]BE22.02.2012
FI22.02.2012
LT22.02.2012
NL22.02.2012
GR23.05.2012
IS22.06.2012
PT22.06.2012
Former [2012/36]LT22.02.2012
NL22.02.2012
GR23.05.2012
IS22.06.2012
Former [2012/35]LT22.02.2012
NL22.02.2012
IS22.06.2012
Former [2012/34]LT22.02.2012
IS22.06.2012
Former [2012/33]LT22.02.2012
Documents cited:Search[A]WO9854170  (CELGENE CORP [US], et al) [A] 1-14 * page 5, line 24 - page 6, line 18 *;
 [PA]WO2007084455  (SCHERING CORP [US], et al) [PA] 1-14* page 4, line 11 - page 9, line 24 *
International search[A]US2006019928  (LIN JAMES [US], et al);
 [A]US2006199836  (TURTLE ERIC D [US], et al);
 [A]CN1844118  (TIANJIN HEMEI BIOTECHNOLOGY CO [CN]);
 [XP]CN1939922  (HEMEI BIOLOG TECHNOLOGY CO LTD [CN])
by applicantWO9854170
 US2006019928
 US2006199836
 CN1844118
 CN1939922
 WO2007084455
    - TRACEY ET AL., NATURE, (1987), vol. 330, pages 662 - 4
    - HINSHAW ET AL., CIRC SHOCK, (1990), vol. 30, pages 279 - 92
    - DEZUBE ET AL., LAUCET, (1990), vol. 335, no. 8690, page 662
    - MILLAR ET AL., LAUCET, (1989), vol. 2, no. 8665, pages 712 - 714
    - BETOLINNI ET AL., NATURE, (1986), vol. 319, pages 516 - 8
    - CALCI. TISSUE INT. (US), (1990), vol. 46, pages 3 - 10
    - HOLLER ET AL., BLOOD, (1990), vol. 75, no. 4, pages 1011 - 1016
    - GRAU ET AL., N. ENGL. J. MED., (1989), vol. 320, no. 24, pages 1586 - 91
    - PIGNET ET AL., NATURE, (1990), vol. 344, pages 245 - 7
    - BISSONNETTE ET AL., INFLAMMATION, (1989), vol. 13, no. 3, pages 329 - 339
    - BAUGHMAN ET AL., J. LAB. CLIN. MED., (1990), vol. 115, no. 1, pages 36 - 42
    - UADDER ET AL., PNAS, (1990), vol. 87
    - DUH ET AL., PROC. NAT. ACAD. SCI., (1989), vol. 86, pages 5974 - 8
    - POLL ET AL., PROC. NAT. ACAD. SCI., (1990), vol. 87, pages 782 - 5
    - MONTO ET AL., BLOOD, (1990), vol. 79, page 2670
    - POLL ET AL., AIDS RES. HUMAN RETROVIRUS, (1992), pages 191 - 197
    - LOME; CHENG, DRUGS OF THE FUTUNE, (1992), vol. 17, no. 9, pages 799 - 807
    - YU YANYAN, CHINESE JOURNAL OF INTERNAL MEDICINE, (1996), vol. 35, pages 28 - 31
    - JOURNAL OF QIQIHAR MEDICAL COLLEG, (2001), vol. 22, no. 10, pages 1119 - 1120
    - YOSHIOKA ET AL., HEPATOLOGY, (1989), vol. 10, pages 769 - 777
    - WANG XIN ET AL., CHINESE JOURNAL OF INFECTIOUS DISEASES, (1997), vol. 15, no. 2, pages 85 - 88
    - ABBOUD H.E., KIDNEY INT., (1993), vol. 43, pages 252 - 267
    - EGIDO J. ET AL., KIDNEY INT., (1993), vol. 43, no. 39, pages 59 - 64
    - CAMMUSI G. ET AL., KIDNEY INT., vol. 43, no. 39, page 32.36
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.